JNCCN Journal of the National Comprehensive Cancer Network

publication venue for

Nonmelanoma Skin Cancer in Childhood and Young Adult Cancer Survivors Previously Treated With Radiotherapy. 17:237-243. 2019
Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer. 17:194-200. 2019
Antimicrobial stewardship in patients with cancer: The time is now. 17:772-775. 2019
Geriatric oncology education for the oncologist is overdue. 16:336-338. 2018
Frequency, morbidity, and mortality of bone metastases in advanced hepatocellular carcinoma. 16:50-58. 2018
NCCN Guidelines® insights breast cancer, version 1.2017: Featured updates to the NCCN Guidelines. 15:433-451. 2017
Clinical practice guidelines in oncology. 15:230-269. 2017
Electronic rapid fitness assessment: A novel tool for preoperative evaluation of the geriatric oncology patient. 15:172-179. 2017
Neoadjuvant therapy for rectal cancer affects lymph node yield and status without clear implications on outcome: The case for eliminating a metric and using preoperative staging to guide therapy. 14:1528-1534. 2016
Bladder Cancer, Version 2.2016 Featured Updates to the NCCN Guidelines. 14:1213-1224. 2016
High Body Mass Index in Elderly Patients with DLBCL Treated with Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex. 14:1274-1281. 2016
Ovarian cancer, version 1.2016: Clinical practice guidelines in oncology. 14:1134-63. 2016
Genetic/familial high-risk assessment: Colorectal version 1.2016: Clinical practice guidelines in oncology. 14:1010-30. 2016
NCCN Guidelines^® insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines. 14:945-58. 2016
Whole-exome sequencing in two extreme phenotypes of response to VEGF-targeted therapies in patients with metastatic clear cell renal cell carcinoma. 14:820-4. 2016
NCCN guidelines^® insights survivorship, version 1.2016 featured updates to the NCCN Guidelines. 14:715-24. 2016
Imatinib treatment of lymphangiomatosis (generalized lymphatic anomaly). 14:383-6. 2016
Melanoma, version 2.2016 clinical practice guidelines in oncology. 14:450-73. 2016
NCCN guidelines and quality cancer care: Where have we come from, and where should we be going?. 14:373-7. 2016
NCCN guidelines^® insights multiple myeloma, version 3.2016 featured updates to the NCCN guidelines. 14:389-400. 2016
Breast cancer, version 1.2016 featured updates to the NCCN guidelines. 13:1475-85. 2015
Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology. 13:1534-61. 2015
Anemia and functional disability in older adults with cancer. 13:1233-9. 2015
Testicular cancer, version 2.2015: Clinical pactice guidelines in oncology. 13:772-99. 2015
Emerging treatment options for B-Cell Lymphomas. 13:666-9. 2015
Management of dermatologic toxicities. 13:686-9. 2015
NCCN roundtable: What are the characteristics of an optimal clinical practice guideline?. 13:640-2. 2015
NCCN roundtable:value-based decision-making at the bedside. 13:659-61. 2015
Cancer-associated venous thromboembolic disease, version 1.2015: Featured updates to the NCCN Guidelines. 13:1079-95. 2015
Central nervous system cancers, version 1.2015: Featured updates to the NCCN guidelines. 13:1191-202. 2015
Cervical cancer, version 2.2015: Featured updates to the NCCN guidelines featured updates to the NCCN guidelines. 13:395-404; quiz 404. 2015
Guideline familiarity predicts variation in self-reported use of routine surveillance PET/CT by physicians who treat head and neck cancer. 13:69-77. 2015
Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines. 13:847-55; quiz 856. 2015
Metastatic insulinoma: Current molecular and cytotoxic therapeutic approaches for metastatic well-differentiated panNETs. 13:139-44. 2015
Rectal cancer, version 2.2015: Featured updates to the NCCN guidelines. 13:719-28; quiz 728. 2015
The right drug for the right patient: Navigating systemic therapy options in metastatic renal cell carcinoma and future directions. 13:1168-70. 2015
Hepatobiliary cancers, version 2.2014. 12:1152-82. 2014
Survivorship: Immunizations and Prevention of Infections, Version 2.2014. 12:1098-111. 2014
Systemic therapy for advanced appendiceal adenocarcinoma: An analysis from the NCCN oncology outcomes database for colorectal cancer. 12:1123-30. 2014
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. 12:907-13. 2014
Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions. 12:235-43. 2014
Chronic myelogenous leukemia, version 1.2015. 12:1590-610. 2014
Diet and physical activity in the prevention of colorectal cancer. 12:1721-6. 2014
Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. 12:513-9. 2014
Non-small cell lung cancer, version 1.2015: Clinical practice guidelines in oncology. 12:1738-61. 2014
Senior adult oncology, version 2.2014: Clinical practice guidelines in oncology. 12:82-126. 2014
Survivorship: Introduction and definition: Clinical practice guidelines in oncology. 12:34-45. 2014
Thyroid carcinoma, version 2.2014: Featured updates to the NCCN guidelines. 12:1671-80; quiz 1680. 2014
Study using the NCCN guidelines for palliative care to screen patients for palliative care needs and referral to palliative care specialists. 11:1087-96. 2013
Breast cancer, version 3.2013. 11:753-60; quiz 761. 2013
Systemic therapy for small cell lung cancer. 11:780-7. 2013
Metastatic colon cancer, version 3.2013: Featured updates to the NCCN guidelines. 11:141-52; quiz 152. 2013
Second-Generation epidermal growth factor receptor tyrosine kinase inhibitors in lung cancers. 11:161-9. 2013
Multiple myeloma, version 1.2013: Featured updates to the NCCN guidelines. 11:11-7. 2013
Non-Hodgkin's Lymphomas, version 3.2012: Featured updates to the NCCN guidelines. 10:1487-98. 2012
Rectal cancer. 10:1528-64. 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m² for patients with recurrent or metastatic head and neck squamous cell cancer. 10:1391-8. 2012
BRAF mutations in colorectal cancer: Clinical relevance and role in targeted therapy. 10:1456-8. 2012
Hypofractionated whole breast radiation and partial breast radiation for early-stage breast cancers: An update on progress. 10:1161-4. 2012
Acute myeloid leukemia. 10:984-1021. 2012
Modern approaches to localized cancer of the esophagus. 9:902-11. 2011
NCCN task force report: Optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy. 9:S1-29. 2011
NCCN task force report: Tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia. 9:S1-25. 2011
Identifying older patients with acute myeloid leukemia who may be candidates for reduced-intensity hematopoietic cell transplantation. 9:319-29; quiz 330. 2011
Fertility-sparing surgery in early-stage cervical cancer: Indications and applications. 8:1435-8. 2010
Geographic proximity and racial disparities in cancer clinical trial participation. 8:1343-51. 2010
Complications of multiple myeloma therapy, part 2: Risk reduction and management of venous thromboembolism, osteonecrosis of the jaw, renal complications, and anemia. 8:S13-20. 2010
Concordance with NCCN colorectal cancer guidelines and ASCO/NCCN quality measures: An NCCN institutional analysis. 7:895-904. 2009
Lung cancer screening. 6:271-5. 2008
Novel systemic therapies for small cell lung cancer. 6:315-22. 2008
Small cell lung cancer. 6:294-314. 2008
Point: Combination versus single-agent chemotherapy: The argument for sequential single agents. 5:668-72. 2007
NCCN Task Force report: Positron Emission Tomography (PET)/Computed Tomography (CT) scanning in cancer. 5:S1-22; quiz S23-2. 2007
Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology. 3:772-89. 2005
Chronic myelogenous leukemia: Clinical practice guidelines in oncology. 3:732-55. 2005
Comparative studies on erythropoietic agents. 3:S46-9. 2005
New approaches in the management of lung cancer. 3:S22-4. 2005
Proteasome inhibitors in non-Hodgkin's lymphoma. 3:S34-6. 2005
Update: NCCN breast cancer clinical practice guidelines. 3:S7-11. 2005
Update: NCCN prostate cancer clinical practice guidelines. 3:S29-33. 2005
Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II.. 2 Suppl 4:S21-2. 2004
New advances in taxane therapy: the next generation.. 2 Suppl 3:S-5-8. 2004
New advances in the treatment of gastric cancer.. 2 Suppl 3:S-29-33. 2004
Update: NCCN non-small cell lung cancer clinical practice guidelines.. 2 Suppl 3:S-9-13. 2004
Counterpoint: The case Against adjuvant high-dose interferon-α for melanoma patients. 2:69-72. 2004
Prostate cancer: nomograms and risk assessment models.. 1 Suppl 3:S-49-54. 2003
Update: colorectal cancer guidelines.. 1 Suppl 3:S-9-16. 2003
Psychological issues in geriatric oncology. 1:381-92. 2003
Update: prostate cancer early detection clinical practice guidelines.. 1 Suppl 1:S57-60. 2003
Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines. 15:563-573. 2017
Hodgkin lymphoma version 1.2017. 15:608-638. 2017
Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology. 15:504-535. 2017
Colon cancer, version 1.2017: Clinical practice guidelines in oncology. 15:370-398. 2017
NCCN guidelines® insights chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017: Featured updates to the NCCN guidelines. 15:293-311. 2017
Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017: Featured updates to the NCCN guidelines. 15:9-20. 2017
Myelodysplastic syndromes, version 2.2017: Clinical practice guidelines in oncology. 15:60-87. 2017
Vulvar cancer, version 1.2017: Clinical practice guidelines in oncology. 15:92-120. 2017
Myeloproliferative neoplasms, version 2.2017: Clinical Practice Guidelines in oncology. 14:1572-1611. 2016
NCCN guidelines^® insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN guidelines. 14:1505-1512. 2016
Older adult oncology, version 2.2016: Featured updates to the NCCN guidelines. 14:1357-1370. 2016
Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology. 14:1286-1312. 2016
NCCN Guidelines® insights: Non-Hodgkin's lymphomas, version 3.2016 featured updates to the NCCN guidelines. 14:1067-79. 2016
NCCN Guidelines®: Insights malignant pleural mesothelioma, version 3.2016. 14:825-36. 2016
Prevention and treatment of cancer-related infections, version 2.2016. 14:882-913. 2016
Basal cell skin cancer, version 1.2016: Clinical practice guidelines in oncology. 14:574-97. 2016
Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines. 14:509-19. 2016
The role of biosimilars. 14:626-9. 2016
Invasive breast cancer version 1.2016. 14:324-54. 2016
NCCN guidelines® Insights: Non-small cell lung cancer, version 4.2016 Featured updates to the NCCN guidelines. 14:255-64. 2016
Diffuse large b-cell lymphoma version 1.2016: Clinical practice guidelines in oncology. 14:196-231. 2016
Genetic/familial high-risk assessment: Breast and ovarian, version 2.2015 Featured updates to the NCCN guidelines. 14:153-62. 2016
Acute lymphoblastic leukemia, version 2.2015: Clinical practice guidelines in oncology. 13:1240-79. 2015
Evaluating the potential role of PET/CT in the posttreatment surveillance of head and neck cancer. 13:252-4. 2015
Multiple myeloma, version 2.2016: Clinical practice guidelines in oncology. 13:1398-435. 2015
Where exactly does ponatinib fit in chronic myelogenous leukemia?. 12:1615-20. 2014
Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer. 11:286-90. 2013
Clinical practice guidelines in oncology. 9:1238-90. 2011
Psychostimulants for cancer-related fatigue. 8:933-942. 2010
Colorectal cancer screening: Clinical practice guidelines in oncology™. 8:8-61. 2010
Hepatobiliary cancers. 7. 2009
Counterpoint: Hyperthermia with radiation therapy for chest wall recurrences. 5:345-8. 2007
NCCN Task Force report: Bone health and cancer care. 4:S1-20; quiz S21-2. 2006
Elucidation of the molecular mechanisms of malignant bone tumors: Refining diagnosis and identifying novel targets for treatment. 3:142-6. 2005
NCCN biosimilars white paper: Regulatory, scientific, and patient safety perspectives 2011
NCCN task force report: Bone health in cancer care 2009
Antiemesis 2009
Uterine neoplasms 2009
Bladder cancer 2009
Myeloid growth factors 2009
Cervical cancer 2008
Cervical cancer screening 2008
Breast cancer risk reduction: Clinical Practice Guidelines in Oncology™ 2007
Genetic/familial high-risk assessment: Breast and ovarian. Clinical Practice Guidelines in Oncology™ 2006
Neuroendocrine tumors: Clinical Practice Guidelines in Oncology™ 2006
Guidelines for NHL: Updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia. 12:797-800. 2014
International adaptation and use of NCCN guidelines. 12:838-41. 2014
NCCN Bone Health Task Force: Key recommendations. 12:813-6. 2014
Point/counterpoint: Early detection of prostate cancer: Do the benefits outweigh the consequences?. 12:768-71. 2014
Evolving roles of histologic evaluation and molecular/genomic profiling in the management of endometrial cancer 2018
Emerging role of CAR T cells in Non-Hodgkin's Lymphoma 2017
Follow-up management of patients with testicular cancer: A multidisciplinary consensus-based approach 2015
Hodgkin Lymphoma, version 2.2015 2015
Non-Small cell lung cancer, version 6.2015: Featured updates to the NCCN guidelines 2015
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms 2015
Anaplastic thyroid carcinoma, version 2.2015 2015
Breast cancer risk reduction, version 2.2015 clinical practice guidelines in oncology clinical practice guidelines in oncology 2015
Breast cancer version 2.2015: Clinical practice guidelines in oncology 2015
Cancer-related fatigue, version 2.2015 2015
Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015 2015
Colorectal cancer screening, version 1.2015: Featured updates to the NCCN guidelines 2015
Esophageal and esophagogastric junction cancers, Version 1.2015 2015
Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines 2015
Lung cancer screening, version 1.2015: Featured updates to the NCCN guidelines 2015
Myelodysplastic syndromes, version 2.2015 featured updates to the NCCN guidelines 2015
Neuroendocrine tumors, version 1.2015 2015
Role of repeat resection in non-muscle-invasive bladder cancer 2015
Spine radiosurgery in the management of renal cell carcinoma metastases 2015
Uterine sarcoma, version 1.2016: Featured updates to the NCCN Guidelines 2015
Colon cancer, version 3.2014 2014
Occult primary, version 3.2014; Featured updates to the NCCN guidelines 2014
Survivorship: Cognitive function, Version 1.2014; Clinical practice guidelines in oncology 2014
Dermatofibrosarcoma protuberans, version 1.2014 2014
Non-Hodgkin's lymphomas, version 2.2014 2014
Survivorship: Fatigue, version 1.2014 - Clinical practice guidelines in oncology 2014
Cervical cancer screening 2014
Kidney cancer, version 2.2014 2014
Sentinel lymph node mapping for endometrial cancer: A modern approach to surgical staging 2014
Survivorship: Sexual dysfunction (female), version 1.2013 2014
Uterine neoplasms, version 1.2014 2014
Breast cancer version 3.2014 2014
Central nervous system cancers, Version 2.2014: Featured updates to the NCCN guidelines 2014
Genetic/familial high-risk assessment: Breast and ovarian, version 1.2014 2014
Head and neck cancers, version 2.2014 2014
Melanoma, version 4.2014: Featured updates to the NCCN guidelines 2014
Merkel cell carcinoma, version 1.2014. 2014
Non-Hodgkin's lymphomas, version 4.2014 2014
Palliative care, version 1.2014 featured updates to the NCCN guidelines 2014
Pertuzumab in the treatment of HER2+ breast cancer 2014
Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology 2014
Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines 2014
Survivorship: Healthy lifestyles, version 2.2014 2014
Survivorship: Nutrition and weight management, version 2.2014 2014
Survivorship: Pain version 1.2014 - Clinical practice guidelines in oncology 2014
Survivorship: Screening for cancer and treatment effects, version 2.2014 2014
Survivorship: Sleep disorders, version 1.2014 2014
Survivorship: sexual dysfunction (male), version 1.2013. 2014
Colorectal cancer screening: Clinical practice guidelines in oncology 2013
Postconsolidation maintenance and monitoring in patients with acute promyelocytic leukemia 2013
Prostate cancer, version 1.2014: Featured updates to the NCCN Guidelines 2013
Chronic myelogenous leukemia, version 1.2014: Featured updates to the NCCN guidelines 2013
Translating genomics in cancer care 2013
Venous thromboembolic disease: Clinical Practice Guidelines in Oncology 2013
Ovarian cancer, version 2.2013: Featured updates to the NCCN guidelines 2013
Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines 2013
Central nervous system cancers 2013
Adult cancer pain 2013
Head and Neck Cancers, version 2.2013 2013
NCCN task force report: Bone health in cancer care 2013
Non-small cell lung cancer, version 2.2013: Featured updates to the NCCN guidelines 2013
Bladder cancer: Clinical practice guidelines in oncology 2013
Gastric cancer, version 2.2013 2013
Localized Colon Cancer, version 3.2013 2013
Melanoma, version 2.2013: Featured updates to the NCCN guidelines 2013
Thymomas and thymic carcinomas 2013
Progress in the management of melanoma in 2013 2013
Recent advances in the treatment of non-Hodgkin's lymphomas 2013
Systemic therapy for metastatic colorectal cancer 2013
Cervical cancer: Clinical practice guidelines in oncology 2013
Non-Hodgkin's lymphomas, version 1.2013: Featured updates to the NCCN guidelines 2013
Distress Management: Clinical practice guidelines in oncology 2013
Impact of the 7th edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers 2013
Penile cancer 2013
Small cell lung cancer: Clinical practice guidelines in oncology 2013
Ovarian cancer, version 3.2012: Featured updates to the NCCN guidelines 2012
Prevention and treatment of cancer-related infections 2012
Non-small cell lung cancer: Clinical practice guidelines in oncology 2012
Palliative care: Clinical practice guidelines in oncology 2012
Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013: Featured updates to the NCCN guidelines 2012
Prostate cancer, version 3.2012: Featured updates to the NCCN Guidelines 2012
Acute lymphoblastic leukemia: Clinical practice guidelines in oncology 2012
Exocrine pancreas cancer and thromboembolic events: A systematic literature review 2012
Metastatic breast cancer, version 1.2012: Featured updates to the NCCN guidelines 2012
Neuroendocrine tumors: Clinical practice guidelines in oncology 2012
Systemic therapy for advanced pancreatic neuroendocrine tumors: An update 2012
Cancer- and chemotherapy-induced anemia: Clinical practice guidelines in oncology 2012
Hodgkin lymphoma, version 2.2012: Featured updates to the NCCN guidelines 2012
The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement 2012
Anal carcinoma, version 2.2012: Featured updates to the NCCN guidelines 2012
Antiemesis 2012
Late cardiovascular toxicity following chemotherapy for germ cell tumors 2012
Testicular cancer 2012
Controversies in the management of regional nodes in melanoma 2012
Dermatofibrosarcoma protuberans 2012
Melanoma 2012
Mucosal melanoma of the head and neck 2012
Lung cancer screening: Clinical practice guidelines in oncology 2012
Senior adult oncology: Clinical practice guidelines in oncology 2012
Chronic myelogenous leukemia 2012
Malignant pleural mesothelioma 2012
Novel therapies in phase II and III trials for malignant pleural mesothelioma 2012
NCCN molecular testing white paper: Effectiveness, efficiency, and reimbursement 2011
Occult primary 2011
Colon cancer. 2011
Multiple myeloma clinical practice guidelines in oncology 2011
Small cell lung cancer clinical practice guidelines in oncology 2011
Surgery for early-stage small cell lung cancer 2011
Hodgkin lymphoma: Clinical practice guidelines in oncology 2011
Kidney cancer 2011
Esophageal and esophagogastric junction cancers 2011
Venous thromboembolic disease: Clinical practice guidelines in oncology 2011
Current recommendations for systemic therapy of recurrent and/or metastatic head and neck squamous cell cancer 2011
Head and neck cancers: Clinical practice guidelines in oncology 2011
Non-Hodgkin's lymphomas: Clinical practice guidelines in oncology 2011
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma 2011
Central nervous system cancers: Clinical practice guidelines in oncology 2011
Acute myeloid leukemia: Clinical practice guidelines in oncology 2011
Invasive breast cancer: Clinical practice guidelines in oncology 2011
Epithelial ovarian cancer 2011
Cervical Cancer Screening Clinical Practice Guidelines in Oncology 2010
Cervical cancer: Clinical practice guidelines in oncology 2010
Thymic malignancies 2010
Thyroid carcinoma 2010
Breast cancer risk reduction 2010
Breast cancer: Noninvasive and special situations 2010
Adult cancer pain: Clinical practice guidelines in oncology 2010
Basal cell and squamous cell skin cancers 2010
Cancer-related fatigue 2010
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. 2010
Non-small cell lung cancer: Clinical practice guidelines in oncology 2010
Genetic/familial high-risk assessment: Breast and ovarian - Clinical practice guidelines in oncology™ 2010
Medullary carcinoma: Clinical practice guidelines in oncology™ 2010
Distress management: Clinical practice guidelines in oncology™ 2010
Gastric cancer: A primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease 2010
Gastric cancer: Clinical practice guidelines in oncology™ 2010
An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma 2010
Non-Hodgkin's lymphomas clinical practice guidelines in oncology 2010
Prostate cancer: Clinical practice guidelines in oncology™ 2010
Anal carcinoma: Clinical practice guidelines in oncology™ 2010
NCCN clinical practice guidelines in oncology. Colorectal cancer screening. 2010
Breast cancer screening and diagnosis: Clinical practice guidelines in oncology™ 2009
NCCN task force report: Management of neuropathy in cancer 2009
Chronic myelogenous leukemia 2009
Multiple myeloma 2009
Colon cancer 2009
Rectal cancer 2009
NCCN Task Force report: Molecular markers in leukemias and lymphomas 2009
NCCN Task Force: Clinical utility of PET in a variety of tumor types 2009
Neuroendocrine tumors 2009
Kidney cancer 2009
Testicular cancer 2009
NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer 2009
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. 2009
Selection of patients with hepatocellular carcinoma for sorafenib 2009
Melanoma 2009
Merkel cell carcinoma 2009
Breast cancer: Clinical Practice Guidelines in Oncology™ 2009
Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: Strategy versus reality 2009
Acute myeloid leukemia 2008
Occult primary: Clinical practice guidelines in oncology 2008
Strategy for incorporating molecular and cytogenetic markers into acute myeloid leukemia therapy 2008
Esophageal cancer 2008
Myelodysplastic syndromes 2008
Ovarian cancer 2008
Venous thromboembolic disease 2008
Head and neck cancers 2008
The role of inhibitors of the epidermal growth factor in management of head and neck cancer 2008
NCCN Task Force report: Breast cancer in the older woman 2008
Cancer- and chemotherapy-induced anemia 2008
Hodgkin disease/lymphoma 2008
Central nervous system cancers: Clinical Practice Guidelines in Oncology™ 2008
NCCN Task Force Report: Oral chemotherapy 2008
Non-small cell lung cancer 2008
Non-Hodgkin's lymphomas 2008
Review of the treatment of mycosis fungoides and Sézary syndrome: A stage-based approach 2008
Prevention and treatment of cancer-related infections 2008
NCCN task force report: Prevention and management of mucositis in cancer care 2008
Cancer-related fatigue clinical practice guidelines in oncology 2007
Update on psychotropic medications for cancer-related fatigue 2007
Colon cancer 2007
Rectal cancer 2007
Targeted strategies in the treatment of metastatic colon cancer 2007
Prostate cancer 2007
Investigational therapies for metastatic thyroid carcinoma 2007
Thyroid carcinoma 2007
Basal cell and squamous cell skin cancers 2007
Chronic myelogenous leukemia 2007
Dermatofibrosarcoma protuberans 2007
Bone cancer: Clinical Practice Guidelines in Oncology™ 2007
The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™ 2007
Growth factors in leukemia 2007
Multiple myeloma: Clinical practice guidelines in oncology™ 2007
Myeloid growth factors: Clinical practice guidelines in oncology™ 2007
Antiemesis: Clinical practice guidelines in Oncology™ 2007
Distress management: Clinical practice guidelines in Oncology™ 2007
Bladder cancer clinical practice guidelines in oncology 2006
Importance of node dissection in relation to neoadjuvant and adjuvant therapy 2006
Kidney cancer clinical practice guidelines in oncology 2006
Testicular cancer clinical practice guidelines in oncology 2006
Ovarian cancer: Clinical Practice Guidelines in Oncology™ 2006
Venous thromboembolic disease: Clinical practice guidelines in Oncology™ 2006
Hepatobiliary cancers clinical practice guidelines in oncology 2006
Melanoma: Clinical practice guidelines in oncology™ 2006
Merkel cell carcinoma: Clinical practice guidelines in oncology™ 2006
Role of dermatologists in treating melanoma 2006
Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™ 2006
Pulmonary neuroendocrine tumors: What (little) do we know? 2006
Small cell lung cancer: Clinical Practice Guidelines in Oncology™ 2006
Uterine cancers: Clinical practice guidelines in oncology™ 2006
Colorectal cancer screening: Clinical Practice Guidelines in oncology™ 2006
Esophageal cancer: Clinical Practice Guidelines in oncology™ 2006
Gastric cancer: Clinical Practice Guidelines in oncology™ 2006
Favorable early-stage Hodgkin lymphoma 2006
Hodgkin disease/lymphoma: Clinical practice guidelines in oncology™ 2006
Non-Hodgkin's lymphoma: Clinical practice guidelines in oncology™ 2006
Acute myeloid leukemia: Clinical Practice Guidelines in Oncology 2006
Myelodysplastic syndromes: Clinical Practice Guidelines in Oncology 2006
Strategies for the treatment of acute promyelocytic leukemia 2006
Central nervous system cancers Clinical Practice Guidelines in Oncology 2005
Anal canal cancer clinical practice guidelines in oncology 2005
Colon cancer clinical practice guidelines 2005
Rectal cancer clinical practice guidelines in oncology 2005
Breast cancer: Clinical practice guidelines in oncology 2005
Head and neck cancers: Clinical practice guidelines 2005
Partial-breast radiation for early staged breast cancers: Hypothesis, existing data, and a planned phase III trial 2005
Thyroid carcinoma: Clinical practice guidelines 2005
Bone cancer: Clinical practice guidelines 2005
Occult primary cancer: Clinical practice guidelines 2005
Bladder cancer: Clinical practice guidelines in oncology 2005
Kidney cancer: Clinical practice guidelines 2005
Testicular cancer: Clinical practice guidelines 2005
The integration of chemotherapy and surgery for bladder cancer 2005
Cervical cancer guidelines. Clinical practice guidelines in oncology. 2004
Cervical cancer screening clinical practice guidelines in oncology. 2004
Ovarian cancer clinical practice guidelines. 2004
Antiemesis clinical practice guidelines in oncology. 2004
Fever and neutropenia clinical practice guidelines. 2004
Non-Hodgkin's lymphoma clinical practice guidelines. 2004
Surgery in the management of small cell lung cancer 2004
Point: Sentinel lymph node biopsy is indicated for patients with DCIS 2003
Controversies in the surgical management of gastric cancer 2003
Anal canal cancer. Clinical practice guidelines in oncology. 2003
Anemia clinical practice guidelines in oncology. 2003
Colon cancer. Clinical practice guidelines in oncology. 2003
Rectal cancer. Clinical practice guidelines in oncology. 2003
Ten years of progress in head and neck cancers 2012
Ten years of progress in renal cell carcinoma 2012
Incorporation of crizotinib into the NCCN guidelines 2011
Lessons from ASH 2010: A focus on NHL 2011
In defense of hepatic arterial infusion for hepatic metastases of colorectal cancer: Commentary 2010

VIVO Weill Cornell Medical College

JNCCN Journal of the National Comprehensive Cancer Network Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)